Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001829126-22-008677
Filing Date
2022-04-25
Accepted
2022-04-25 14:55:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D titan_sc13d.htm SC 13D 133629
2 PRESS RELEASE titan_ex99-1.htm EX-99.1 4391
3 JOINT FILING AGREEMENT titan_ex99-2.htm EX-99.2 6795
  Complete submission text file 0001829126-22-008677.txt   146353
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-46083 | Film No.: 22849383
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Filed by) CIK: 0001817604 (see all company filings)

EIN.: 833953038 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D